The National Health Commission today issued the “Obesity Diagnosis and Treatment Guidelines”. This is the first authoritative guide for multidisciplinary diagnosis and treatment of obesity in China. It is of great significance in standardizing the clinical diagnosis and treatment of obesity in China and raising the level of homogenization of obesity diagnosis and treatment in medical institutions. In recent years, the prevalence of overweight and obese people in our country has continued to rise. As an independent type of chronic disease and an important causative factor for various chronic diseases, obesity has become a major public health problem in China and is the sixth leading risk factor for death and disability in China. The multidisciplinary collaborative diagnosis and treatment model can effectively improve the level of obesity diagnosis and treatment.

The National Health Commission today issued the “Obesity Diagnosis and Treatment Guidelines”. This is the first authoritative guide for multidisciplinary diagnosis and treatment of obesity in China. It is of great significance in standardizing the clinical diagnosis and treatment of obesity in China and raising the level of homogenization of obesity diagnosis and treatment in medical institutions. In recent years, the prevalence of overweight and obese people in our country has continued to rise. As an independent type of chronic disease and an important causative factor for various chronic diseases, obesity has become a major public health problem in China and is the sixth leading risk factor for death and disability in China. The multidisciplinary collaborative diagnosis and treatment model can effectively improve the level of obesity diagnosis and treatment.